课题基金 / 基金详情

Experimental study on blood-inner ear barrier function in MRP1 and p-glycoprotein gene knockout mice

Experimental study on blood-inner ear barrier function in MRP1 and p-glycoprotein gene knockout mice
MRP1和p-糖蛋白基因敲除小鼠血-内耳屏障功能的实验研究
批准号:
13671776
负责人:
SAITO Takehisa
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

SAITO Takehisa的其他基金

相似基金

相关文献

中文摘要
翻译
本研究利用mdr1a p-gp基因敲除小鼠[mdr1a(-/-)小鼠]和野生型mdr1a(+/+)小鼠研究了p-糖蛋白(p-gp)在内耳中的功能。药代动力学分析表明,与mdr1a(+/+)小鼠相比,mdr1a(-/-)小鼠对p-gp转运药物如阿霉素和长春花碱表现出超敏反应,并且这些药物在内耳的积累增加。然而,使用耳毒性药物顺铂后未检测到p-gp积累增加,表明p-gp对挤压药物具有选择性。使用听觉脑干反应的电生理学研究显示,仅在mdr1a(-/-)小鼠中,单独给予阿霉素或长春花碱后,波I和波I至V峰间潜伏期的阈值升高和延长。此外,在mdr1a(+/+)小鼠中,与环孢素A共同给药对p-gp功能的抑制导致阿霉素和长春花碱在内耳的积累增加。在环孢素A预处理后,单独使用阿霉素或长春花碱治疗的mdr1a(+/+)小鼠检测到听力障碍。由此可见,mdr1a p-gp作为外排泵,可抑制阿霉素、长春花碱等p-gp底物引起的野生型小鼠耳毒性。免疫组化法检测了多药耐药蛋白1 (MRP1)在大鼠耳蜗、豚鼠前庭迷路和内淋巴囊的表达。MRP1在血管纹外侧壁、螺旋韧带、螺旋突起和摩尺蠖的耳蜗神经纤维中检测到。此外,MRP1在壶腹嵴、胞室、囊泡和内淋巴囊上皮细胞的上皮细胞中被发现。由于p-gp和MRP1具有挤压泵的作用,它们可能参与特定药物穿过血内耳屏障的双极渗透屏障,导致耳蜗、前庭器官和内淋巴囊内的毒性物质和治疗药物浓度较低,在血内耳屏障中起重要作用。少
英文摘要
The present study investigated the p-glycoprotein (p-gp) function in the inner ear using mdr1a p-gp gene knock-out mice [mdr1a(-/-) mice] and wild-type mdr1a(+/+) mice. Pharmacokinetic analyses indicated that mdr1a(-/-) mice displayed hypersensitivity to p-gp transported drugs such as doxorubicin (adriamycin) and vinblastine, and increased accumulation of these drugs in the inner ear compared with that in mdr1a(+/+) mice. However, increased accumulation was not detected after administering with ototoxic drug cisplatin, indicating that p-gp had a selectivity for extruding drugs. Electrophysiological studies using auditory brainstem response showed elevated thresholds and prolongations of wave I and wave I to V interpeak latencies only in mdr1a(-/-) mice after administering with doxorubicin or vinblastine alone. Furthermore, inhibition of p-gp function by co-administration with cyclosporin A in mdr1a(+/+) mice resulted in increased accumulation of doxorubicin and vinblastine in the inner … More ear. After pretreatment with cyclosporin A, hearing impairment was detected in mdr1a(+/+) mice treated with doxorubicin or vinblastine alone. From these results, it was suggested that mdr1a p-gp, which acts as an efflux pump, prevented ototoxicity induced by p-gp substrate drugs such as doxorubicin and vinblastine in wild-type mice.Expression of multidrug resistance protein 1 (MRP1) was detected in the rat cochlea and in the vestibular labyrinth and endolymphatic sac of the guinea pig by immunohistochemical analyses. MRP1 was detected in the lateral wall of the stria vascularis, spiral ligament, spiral prominence and in the cochlear nerve fibers of the modiolus. Furthermore, MRP1 was found in the epithelial lining of the crista ampullaris, utricle, saccule, and epithelial cells of the endolymphatic sac. Since p-gp and MRP1 act as extrusion pumps, they may participate in a bipolar permeation barrier for selected drugs crossing the blood-inner ear barrier resulting in a low concentration of toxic substances and therapeutic drugs in the cochlea, vestibular organs and endolymphatic sac and play an important role in the blood-inner ear barrier. Less
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
Takehisa Saito, et al.: "Expression of multidrug resistance protein 1(MRP1) in the rat cochlea with special reference to the blood-inner ear barrier"Brain Research. 895(1-2). 253-257 (2001)
Takehisa Saito 等人:“多药耐药蛋白 1 (MRP1) 在大鼠耳蜗中的表达,特别是血液-内耳屏障”脑研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takehisa Saito, et al.: "Expression of p-glycoprotein is associated with that of multidrug resistance protein 1 (MRP1) in the vestibular labyrinth and endolymphatic sac of the guinea pig"Neuroscience Letters. 303(3). 189-192 (2001)
Takehisa Saito 等人:“豚鼠前庭迷路和内淋巴囊中 p-糖蛋白的表达与多药耐药蛋白 1 (MRP1) 的表达相关”《神经科学快报》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takehisa Saito, et al.: "Doxorubicin ototoxicity is induced in mice by combination treatment with cyclosporin A"Acta Otolaryngologica. 121(7). 787-793 (2001)
Takehisa Saito 等人:“通过与环孢菌素 A 联合治疗,在小鼠中诱导多柔比星耳毒性”Acta Otolaryngologica。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
斎藤 武久, 他: "内耳における薬剤排出ポンプ(P-糖蛋白とMRP1)の発現とその機能"頭頸部自律神経. 16. 16-20 (2002)
Takehisa Saito 等人:“内耳中药物流出泵(P-糖蛋白和 MRP1)的表达和功能”头颈自主神经系统。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 14 条
    Evaluation of degeneration and regeneration process of human fungiform taste buds after severing the chorda tympani nerve using confocal laser scanning microscopy in vivo
    • 批准号:
      24592543
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.49万
    • 财政年份:
      2012
    • 负责人:
      SAITO Takehisa
    • 依托单位:
    Study of electron microscopical structure and taste function of regenerated chorda tympani nerve after severance during middle ear surgery
    Pharmacokinetic and functional study on mdr1a p-glycoprotein function in blood-inner ear barrier
    • 批准号:
      11671674
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      1999
    • 负责人:
      SAITO Takehisa
    • 依托单位:
    Comparison of expression of p-glycoprotein and its function between wild type and mdr 1 a p-glycoprotein gene knock-out mice
    • 批准号:
      09671738
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.73万
    • 财政年份:
      1997
    • 负责人:
      SAITO Takehisa
    • 依托单位:
    国内基金
    海外基金
    基于单细胞测序研究HCK调控MRP1磷酸化介导骨肉瘤耐药的分子机制
    • 批准号:
      82373297
    • 项目类别:
      面上项目
    • 资助金额:
      49万元
    • 批准年份:
      2023
    • 负责人:
      刘伟波
    • 依托单位:
    刺芹侧耳交配型基因通过激活转录因子MRP1调控子实体发育的分子机制
    • 批准号:
      32172649
    • 项目类别:
      面上项目
    • 资助金额:
      58万元
    • 批准年份:
      2021
    • 负责人:
      尚俊军
    • 依托单位:
    药物转运体MRP1 mRNA甲基化影响细胞内伊马替尼药物浓度介导胃肠道间质瘤继发性耐药的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2019
    • 负责人:
    • 依托单位:
    Fas通路通过调控MRP1表达促进大肠癌化疗耐药性的分子机制研究
    • 批准号:
      81773191
    • 项目类别:
      面上项目
    • 资助金额:
      50.0万元
    • 批准年份:
      2017
    • 负责人:
      郑浩轩
    • 依托单位: